SUBSCRIBE TO PRESS RELEASES AND REPORTS

– so you don’t miss any information

SUBSCRIBE TO PRESS RELEASES AND REPORTS

– so you don’t miss any information

Press releases (in Swedish)

2024

2024-11-05 14:00 Den första studiedeltagaren har medverkat i NanoEchos dosbekräftelsestudie
2024-11-04 17:15 Valberedningen i NanoEcho har nu utsetts Regulatorisk
2024-10-24 16:20 Styrelsen i NanoEcho drar tillbaka förslag om sammanläggning av aktier Regulatorisk
2024-10-24 08:30 NanoEcho AB (publ): Kvartalsrapport Q3 2024 Regulatorisk MAR
2024-10-23 12:15 NanoEcho bjuder in till presentation av Q3-rapport 2024
2024-10-16 10:30 Rekrytering av studiedeltagare inleds nu i NanoEchos kliniska studie
2024-10-16 07:45 KALLELSE TILL EXTRA BOLAGSSTÄMMA I NANOECHO AB (PUBL) Regulatorisk
2024-10-14 10:30 Vetenskaplig artikel publicerad i Ultrasound in Medicine & Biology
2024-10-11 09:15 Business Sweden stödjer NanoEcho i identifiering av kliniska nyckelaktörer inom rektalcancer
2024-10-04 08:00 NanoEcho tecknar avtal med Celsus Medica för injektion av nanopartiklar i klinisk studie Regulatorisk
Next

NanoEcho’s innovative method, with its high precision, aims to facilitate the differentiation between diseased and healthy tissue and at the same time determine a more precise localization of cancerous tissue. The goal is to provide a more reliable diagnosis of, for example cancer diseases, that has the potential to contribute to cost-effectiveness in the health care.

NanoEcho AB
Scheelevägen 19,
223 63 Lund
info@nanoecho.se

Facebook Linkedin Youtube Envelope
Copyright 2024 NanoEcho © All Rights Reserved.
Privacy policy